Publications:30
Liora S Katz, PhD
About Me
Dr. Liora S. Katz is an Associate Professor, Diabetes Obesity Metabolism Institute and Division of Endocrinology, Diabetes and Bone disease, and Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York. Her academic journey spans over two decades, focusing diabetes and obesity research. Dr. Katz earned her B.Sc. in Biology from the Hebrew University of Jerusalem, her M.Sc. in Structural and Molecular Biochemistry from the Hebrew University of Jerusalem, and her Ph.D. in Biology from Geneva University, Switzerland. She further honed her expertise through a Post-Doctoral Fellowship at the National Institutes of Health (NIH/NIDDK). Driven by a passion for science, she has contributed significantly to the understanding of various aspects of diabetes, ranging from transcriptional regulation and cell differentiation to the identification of key molecular pathways involved in β-cell function and survival. Currently, her main research focus is glucose-induced adaptive expansion and the intricate mechanisms governing beta cell failure amid metabolic overload.
Language
English
Position
ASSOCIATE PROFESSOR | Medicine, Endocrinology, Diabetes and Bone Disease
Publications
Selected Publications
- SIRT2 puts the brakes on human β cell proliferation: therapeutic opportunities and next challenges. Liora S. Katz, Donald K. Scott, Andrew F. Stewart. Journal of Clinical Investigation
- Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity. Liora S. Katz, Emira J. Visser, Kathrin F. Plitzko, Marloes A.M. Pennings, Peter J. Cossar, Isabelle L. Tse, Markus Kaiser, Luc Brunsveld, Christian Ottmann, Donald K. Scott. Nature Communications
- SIRT2 puts the brakes on human β cell proliferation: therapeutic opportunities and next challenges. Liora S. Katz, Donald K. Scott, Andrew F. Stewart. Journal of Clinical Investigation
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Katz has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.